Immunic, Inc. Reports First Quarter 2022 Financial Results and Provides Corporate Update

Go back to Immunic, Inc. Reports First Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: IMUX) Delayed: 14.75 --0 (-0%)
Previous Close $14.75    52 Week High
Open $14.75    52 Week Low
Day High $14.75    P/E N/A 
Day Low $14.75    EPS
Volume